Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036690
Disease: Septicemia
Septicemia
0.010 AlteredExpression disease BEFREE Furthermore, decreased AT1R expression inactivated the MAPK signaling pathway (shown as decreased extracellular signal-regulated kinase and cyclic adenosine 3',5'-monophosphate response element binding protein expression), decreased EF, heart rate, and concentrations of TnT, cTnI, and CK-MB, but increased sepsis rat survival rate. 31433522 2020
CUI: C0038436
Disease: Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
0.010 Biomarker disease BEFREE We discovered that the modified single prolonged stress-exposure induced significant PTSD-like symptoms as well as mildly impaired hippocampal Cornu Ammonis 1 (CA1) subregion cytoarchitecture, but not dentate gyrus neurogenesis, together with a gradual inhibition of TrkA-CREB-ERK signalings in hippocampal CA1 subregion. 31704315 2020
CUI: C0243026
Disease: Sepsis
Sepsis
0.010 AlteredExpression disease BEFREE Furthermore, decreased AT1R expression inactivated the MAPK signaling pathway (shown as decreased extracellular signal-regulated kinase and cyclic adenosine 3',5'-monophosphate response element binding protein expression), decreased EF, heart rate, and concentrations of TnT, cTnI, and CK-MB, but increased sepsis rat survival rate. 31433522 2020
CUI: C0006111
Disease: Brain Diseases
Brain Diseases
0.010 AlteredExpression group BEFREE In conclusion, CBL ameliorated cerebral ischemia injury through reducing neuroinflammation partly <i>via</i> the activation of CREB/PGC-1α pathway and may play a therapeutic role as anti-neuroinflammatory agents in the brain disorders associated with neuroinflammation. 31695614 2019
CUI: C0007102
Disease: Malignant tumor of colon
Malignant tumor of colon
0.010 Biomarker disease BEFREE The present results suggested that miR‑101 may serve a role in colon cancer by directly targeting CREB1. 30816471 2019
CUI: C0013390
Disease: Dysmenorrhea
Dysmenorrhea
0.010 Biomarker phenotype BEFREE Ginsenoside Rf alleviates dysmenorrhea and inflammation through the BDNF-TrkB-CREB pathway in a rat model of endometriosis. 30547177 2019
CUI: C0017601
Disease: Glaucoma
Glaucoma
0.010 Biomarker disease BEFREE The expression of lipocalin 2 (LCN2), monoamine oxidase A (MAOA), hemoglobin subunit β (HBB), paired box 6 (PAX6), fibronectin (FN1) and cAMP responsive element binding protein 1 (CREB1) were demonstrated to be involved in the pathogenesis of glaucoma. 31115504 2019
CUI: C0018621
Disease: Hay fever
Hay fever
0.010 Biomarker disease BEFREE CPEB4 and CREB might be implicated in the pathogenesis of SAR. 30616374 2019
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic
0.010 Biomarker disease BEFREE Additionally, decreased expressions of hippocampal CaMKIIα, p-CaMKIIα (Thr286), CREB1, p-CREB1 (Ser133), and BDNF were observed in the hippocampus of CRF mice, but YGY extract significantly restored these protein expressions. 31055001 2019
CUI: C0026948
Disease: Mycosis Fungoides
Mycosis Fungoides
0.010 AlteredExpression group BEFREE There was downregulation of the expression of phosphatase and tensin homolog (PTEN) and CREB1, known targets of miR-17~92 members; higher gene expression of interleukin-2 and interferon-γ; and a statistically lower average percentage of GATA3<sup>+</sup> dermal cells (6·7% vs. 42·3%), were detected in unilesional MF compared with early MF. 30431147 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.010 GeneticVariation disease BEFREE Dual-luciferase assay and biotin pull-down assay demonstrate that osteoporosis GWAS lead SNPs rs34920465-G and rs6426749-C alleles can respectively bind transcription factors JUN::FOS and CREB1, and upregulate ZBTB40 and ZBTB40-IT1 expression. 30661131 2019
CUI: C0030662
Disease: Gambling, Pathological
Gambling, Pathological
0.010 AlteredExpression disease BEFREE This behavioural change appears superficially similar to the iatrogenic gambling disorder (GD) observed in a sub-set of patients with Parkinson's disease (PD), and has been associated with increased activation of the intra-cellular signalling proteins GSK3β and CREB in the striatum. 30019362 2019
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 AlteredExpression disease BEFREE We found that RBM10 reduces the phosphorylation of CREB via the AKT signalling pathway, suggesting that RBM10 exhibits its effect on lung adenocarcinoma cell proliferation via the RAP1/AKT/CREB signalling pathway. 30955253 2019
Secondary malignant neoplasm of bone
0.010 Biomarker disease BEFREE These findings establish that targeting IL1β-NFKB/CREB-Wnt signalling should be considered for adjuvant therapy to prevent breast cancer bone metastasis. 31676788 2019
Metastatic malignant neoplasm to brain
0.010 PosttranslationalModification disease BEFREE A549 cells selected in vivo to give brain metastases exhibited cisplatin resistance and decreased expression of phosphorylated CREB1. 30093630 2019
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.010 AlteredExpression group BEFREE Furthermore, caffeine (200 μM) at a dose twice higher than the clinically relevant dose (36-130 μM) had minor or no effects on several basic neuronal functions, such as neurite outgrowth, synapse formation, expression of A<sub>1</sub>R and transcription of CREB-1 and c-Fos, further supporting the safety of caffeine for clinical use. 30822423 2019
Metastatic non-small cell lung cancer
0.010 Biomarker disease BEFREE Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer. 30093630 2019
CUI: C0282193
Disease: Iron Overload
Iron Overload
0.010 AlteredExpression disease BEFREE Also, it disturbed the iron homeostasis through increasing C/EBP homologous protein (CHOP), decreasing phosphorylated cAMP responsive element binding protein(P-CREB) and hepcidin levels leading to significant serum and hepatic iron overload. 31499193 2019
CUI: C0409959
Disease: Osteoarthritis, Knee
Osteoarthritis, Knee
0.010 AlteredExpression disease BEFREE The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis. 31182934 2019
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.010 Biomarker disease BEFREE The present results suggested that miR‑101 may serve a role in colon cancer by directly targeting CREB1. 30816471 2019
CUI: C0949664
Disease: Tauopathies
Tauopathies
0.010 AlteredExpression group BEFREE Here, using a transgenic mouse model and primary cell cultures along with quantitative PCR, immunoblotting, and immunohistochemistry, we tested whether the UPR is induced in <i>in vivo</i> and <i>in vitro</i> murine models of tauopathy that are based on expression of mutant tau<sup>P301L</sup> We found no evidence for the UPR in the rTg4510 mouse model, in which mutant tau is transgenically expressed under the control of tetracycline-controlled transactivator protein. 31053641 2019
Idiopathic pulmonary arterial hypertension
0.010 Biomarker disease BEFREE In vivo, participation of Nox1, CREB, and Gremlin1, as well as CREB:CRE binding was corroborated in a rat PAH model. 30802716 2019
CUI: C3887551
Disease: Memory dysfunction
Memory dysfunction
0.010 Biomarker disease BEFREE Although the underlying signaling mechanism for impairment of memory function following induction of ER stress remains elusive, recent studies have highlighted that inactivation of a transcription factor, CREB, which is essential for synaptic function and memory formation, plays an essential role for ER stress-induced synaptic and memory dysfunction. 30477403 2019
CUI: C4725091
Disease: metastatic intraocular melanoma
metastatic intraocular melanoma
0.010 Biomarker disease BEFREE Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma. 31357444 2019
CUI: C0001623
Disease: Adrenal gland hypofunction
Adrenal gland hypofunction
0.010 AlteredExpression phenotype BEFREE Compared with healthy controls, 19 of the 68 genes were found modulated in patients with AI at baseline, 18 of which were restored to control levels 12 weeks after therapy was switched: ARNTL [BMAL] (P = 0.024), CLOCK (P = 0.016), AANAT (P = 0.021), CREB1 (P = 0.010), CREB3 (P = 0.037), MAT2A (P = 0.013); PRKAR1A, PRKAR2A, and PRKCB (all P < 0.010) and PER3, TIMELESS, CAMK2D, MAPK1, SP1, WEE1, CSNK1A1, ONP3, and PRF1 (all P < 0.001). 29846607 2018